1. INTRODUCTION
===============

Methamphetamine (METH) is a drug that is used widely in the world and causes psychiatric disorder. METH causes abnormalities of the dopamine neural transmission in the mesolimbic system, and is thought to cause psychotic symptoms such as hallucinations and delusions \[[@R1],[@R2]\].

Nitric oxide (NO) is involved a variety of mechanisms, regulating the release of neurotransmitters such as dopamine and serotonin, activating N-methyl-D-aspartate (NMDA) receptor, and participating in oxidative stress \[[@R3]-[@R5]\]. Therefore, NO functions may be considered to induce psychotic disorders. The nitric oxide synthase 1 gene (*NOS1*) is a complex gene located at 12q24, consisting of 12 alternative untranslated first exons, termed exon 1a_1l, and 28 exons in a genomic region spanning 149.404Kb. *NOS1* is considered to be a likely candidate gene for schizophrenia owing to its chromosomal location, 12q24, which has been reported to be a susceptibility locus from several linkage studies, and to play a role in producing NO in the human brain \[[@R6]-[@R8]\].

Several genetic association studies showed that single nucleotide polymorphisms (SNPs) in *NOS1* were associated with schizophrenia. Reif *et al.* identified functional SNP (rs41279104) in the promoter region and found an association with schizophrenia \[[@R9]\]. Two other genetic association studies showed a significant association between rs2682826 in exon 29 and haplotype (rs3782221-rs3782219-rs561712-rs3782206) and schizophrenia. Recently, a whole genome association study reported an association between rs6490121 in intron 2 of *NOS1* and schizophrenia \[[@R12]\]. Therefore, *NOS1* is recognized to be candidate gene for schizophrenia \[[@R10],[@R11]\].

Because the symptoms of METH-induced psychosis are similar to those of paranoid type schizophrenia, it may be that the METH-induced psychosis and schizophrenia have common susceptibility genes. Therefore, it would be of interest to examine the association between *NOS1* and METH-induced psychosis. We conducted a genetic association analysis in the Japanese population.

2. MATERIALS AND METHODS
========================

2.1. Subjects
-------------

The subjects in the association analysis were 183 patients (all patients were diagnosed as having METH-induced psychosis; 151 males and 32 females: mean age ± SD 36.7±11.6 years) and 519 healthy controls (268 males and 251 females: mean age ± SD 37.5 ±14.4 years). All subjects were unrelated to each other, ethnically Japanese, and lived in Japan. Among the subjects with METH use disorder, all subjects had a comorbid diagnosis of METH-induced psychosis. One hundred forty-nine subjects with METH use disorder abused or had dependence on drugs other than METH. Cannabinoids were the most frequency abused drugs (31.4%), followed by cocaine (9.09%), LSD (9.09%), opioids (7.69%), and hypnotics (7.69%). Subjects with METH use disorder were excluded if they had a clinical diagnosis of psychotic disorder, mood disorder, anxiety disorder, or eating disorder. The patients were diagnosed according to DSM-IV or ICD-10 criteria with consensus of at least two experienced psychiatrists on the basis of unstructured interviews and a review of medical records. All healthy controls were also psychiatrically screened through unstructured interviews, and those with past individual or family history of drug dependence or an axis 1 disorder such as psychotic or mood disorder were excluded. After describing the study, written informed consent was obtained from each subject. This study was approved by the Ethics Committee at Fujita Health University and each participating institute of the Japanese Genetics Initiative for Drug Abuse (JGIDA).

SNP Selection and Genotyping

We selected seven SNPs (rs2682826, rs3782221, rs3782219, rs561712, rs3782206, rs41279104, rs6490121) in *NOS1* from previous association studies for schizophrenia \[[@R9]-[@R11]\]. We used TaqMan assays (Applied Biosystems) for all SNPs.

2.3. Statistical Analysis
-------------------------

Genotype deviation from the Hardy-Weinberg equilibrium (HWE) was evaluated with the chi-square test (SAS/Genetics, release 8.2, SAS Japan INC, Tokyo, Japan). Marker-trait association was also evaluated with the chi-square test in allele- and genotype-wise analyses. Haplotype frequencies were estimated in a two- to four-marker sliding window fashion and log likelihood ratio tests were performed for global P-values with COCAPHASE program version 3.0.6 \[[@R13]\]. In these haplotype-wise analyses, rare haplotypes (less than 0.05) of either cases or controls were excluded from the association analysis. Power calculation was performed using a statistical program prepared with the Genetic Power Calculator (<http://pngu.mgh.harvard.edu-/~purecell//gpc/>). The level of significance for all statistical tests was 0.05.

3. RESULTS
==========

Genotype frequencies of subjects and controls did not deviate significantly from HWE. No significant association was found between *NOS1* and METH-induced psychosis in the allele/genotype-wise analysis, or in the haplotype analysis (Table **[1](#T1){ref-type="table"}**, **[2](#T2){ref-type="table"}**). Our METH samples were unmatched gender samples for METH-induced psychosis. Therefore, we performed an explorative analysis of gender effects, but no association was detected between any of the SNPs and either sex (Table **[3](#T3){ref-type="table"}**).

In a power analysis, we obtained more than 80% power for the detection of association when we set the genotype relative risk at 1.37-1.6, under a multiplicative model of inheritance.

4. DISCUSSION
=============

We did not find an association between the seven SNPs in *NOS1* and METH-induced psychosis in the allele/genotype-wise or haplotype-wise analysis in these subjects. In several genetic studies of METH, gender effects were found in METH use disorder \[[@R14],[@R15]\]. Because we recognize that our gender samples were unmatched, our negative result may have mainly reflected the effect of male METH-induced psychosis. We therefore conducted an explorative analysis of gender effects, but found none. Since NO has an important role in regulating the release of neurotransmitters such as dopamine and serotonin, *NOS1* is recognized to be a good candidate gene for disorder with psychosis. However, a previous study did not report an association between *NOS1* and schizophrenia \[[@R16]\]. Other genes involved in the activity of *NOS1* may be related to the pathophysiology of psychotic disorders such as schizophrenia and METH-induced psychosis.

Nitric oxide synthase 1 adaptor protein (*NOS1AP*) encodes an adapter protein that binds to *NOS1*and links to a specific target. Recent studies reported evidence of a significant association between *NOS1AP* and schizophrenia \[[@R17],[@R18]\]. Considering these positive results, it will be necessary to replicate the studies using other larger population samples and other phenotypes, such METH-induced psychosis.

A few points of caution must be mentioned with regard to our present negative findings. (1) It is important to evaluate associations between METH use disorder with and without psychosis. However, since we had only a small number of subjects without psychosis, we did not evaluate this association to avoid type I error due to small sample size. to the small number of subjects was a result of limitations of sample collection, since we recruited cases of METH use disorder in psychiatric hospitals. (2) We could not adopt an LD-based strategy and mutation scan, because *NOS1* has a massive gene structure. Therefore, in future studies it will be necessary to evaluate associations between other common variants or rare variants with functional effects and *NOS1* in METH use disorder.

In conclusion, our results suggest that *NOS1* does not play a major role in METH use disorder with psychosis in the Japanese population. However, the number of METH samples used in this study was small, and even though it is difficult to find samples of METH use disorder, it will be necessary to validate or replicate our association in other, larger population samples.
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###### 

Association Study Between *NOS1* and METH-Induced Psychosis

  SNP ID       Phenotype[a](#TF1){ref-type="table-fn"}   MAF[b](#TF2){ref-type="table-fn"}   N     Genotype Distribution[c](#TF3){ref-type="table-fn"}   P-Value                         
  ------------ ----------------------------------------- ----------------------------------- ----- ----------------------------------------------------- --------- ----- ------- ------- --------
  rs41279104   METH-induced psychosis                    0.175                               183   123                                                   56        4     0.413   0.684   0.983
               CON                                       0.175                               519   354                                                   148       17    0.751           
  rs3782221    METH-induced psychosis                    0.421                               183   61                                                    90        32    0.903   0.912   0.891
               CON                                       0.425                               519   175                                                   247       97    0.55            
  rs3782219    METH-induced psychosis                    0.423                               183   61                                                    89        33    0.956   0.611   0.332
               CON                                       0.453                               519   154                                                   260       105   0.803           
  rs561712     METH-induced psychosis                    0.161                               183   128                                                   51        4     0.679   0.716   0.435
               CON                                       0.179                               519   346                                                   160       13    0.274           
  rs3782206    METH-induced psychosis                    0.265                               183   100                                                   69        14    0.663   0.745   0.44
               CON                                       0.245                               519   300                                                   184       35    0.351           
  rs6490121    METH-induced psychosis                    0.407                               183   62                                                    93        28    0.475   0.523   0.532
               CON                                       0.426                               519   175                                                   246       98    0.484           
  rs2682826    METH-induced psychosis                    0.380                               183   67                                                    93        23    0.286   0.175   0.0754
               CON                                       0.329                               519   230                                                   237       52    0.424           

METH:methamphetamine CON: control

MAF: minor allele frequency

M: major allele, m: minor allele

Hardy-Weinberg equilibrium.

###### 

Haplotype-Wise Analysis Between *NOS1* and METH-Induced Psychosis

               Global *P*-value           
  ------------ ------------------ ------- --------------------------------------
  rs41279104                              
               0.631                      
  rs3782221                       0.576   
               0.336                      0.755
  rs3782219                       0.541   
               0.385                      0.799[a](#T2F1){ref-type="table-fn"}
  rs561712                        0.683   
               0.756                      0.673
  rs3782206                       0.810   
               0.428                      0.871
  rs6490121                       0.868   
               0.769                      
  rs2682826                               

Fallin *et al.* reported

###### 

Results of Explorative Analysis Between *NOS1* and METH-Induced Psychosis

  SNP ID       Gender   Phenotype[a](#T3F1){ref-type="table-fn"}   MAF [b](#T3F2){ref-type="table-fn"}   N     Genotype Distribution [c](#T3F3){ref-type="table-fn"}   P-Value                         
  ------------ -------- ------------------------------------------ ------------------------------------- ----- ------------------------------------------------------- --------- ---- -------- ------- --------
  rs41279104   male     METH-induced psychosis                     0.172                                 151   102                                                     46        3    0.399    0.977   0.853
                        CON                                        0.177                                 268   179                                                     83        6    0.310            
               female   METH-induced psychosis                     0.187                                 32    21                                                      10        1    0.884    0.597   0.452
                        CON                                        0.151                                 251   184                                                     58        9    0.110            
  rs3782221    male     METH-induced psychosis                     0.423                                 151   50                                                      74        27   0.966    0.988   0.882
                        CON                                        0.429                                 268   87                                                      132       49   0.931            
               female   METH-induced psychosis                     0.453                                 32    7                                                       21        4    0.0667   0.106   0.574
                        CON                                        0.416                                 251   89                                                      115       47   0.364            
  rs3782219    male     METH-induced psychosis                     0.423                                 151   50                                                      74        27   0.966    0.541   0.326
                        CON                                        0.458                                 268   75                                                      140       53   0.395            
               female   METH-induced psychosis                     0.515                                 32    8                                                       15        9    0.727    0.572   0.293
                        CON                                        0.446                                 251   79                                                      120       52   0.605            
  rs561712     male     METH-induced psychosis                     0.188                                 151   100                                                     45        6    0.741    0.253   0.119
                        CON                                        0.147                                 268   194                                                     69        5    0.689            
               female   METH-induced psychosis                     0.141                                 32    23                                                      9         0    0.354    0.343   0.175
                        CON                                        0.213                                 251   152                                                     91        8    0.200            
  rs3782206    male     METH-induced psychosis                     0.264                                 151   82                                                      58        11   0.865    0.956   0.860
                        CON                                        0.259                                 268   149                                                     99        20   0.529            
               female   METH-induced psychosis                     0.296                                 32    17                                                      11        4    0.317    0.243   0.174
                        CON                                        0.221                                 251   153                                                     85        13   0.789            
  rs6490121    male     METH-induced psychosis                     0.417                                 151   53                                                      70        28   0.565    0.182   0.0736
                        CON                                        0.481                                 268   72                                                      134       62   0.981            
               female   METH-induced psychosis                     0.375                                 32    13                                                      14        5    0.706    0.281   0.0937
                        CON                                        0.486                                 251   73                                                      112       66   0.0904           
  rs2682826    male     METH-induced psychosis                     0.403                                 151   50                                                      80        21   0.218    0.360   0.935
                        CON                                        0.401                                 268   99                                                      123       46   0.464            
               female   METH-induced psychosis                     0.515                                 32    9                                                       13        10   0.290    0.190   0.0952
                        CON                                        0.406                                 251   92                                                      114       45   0.352            

METH:methamphetamine CON:control

MAF: minor allele frequency

M: major allele, m: minor allele

Hardy-Weinberg equilibrium
